These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 32951514)

  • 1. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
    Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
    Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
    Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
    J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left atrial appendage occlusion procedures in patients with heart failure.
    Szymała M; Streb W; Mitręga K; Podolecki T; Mencel G; Kukulski T; Kalarus Z
    Kardiol Pol; 2017; 75(9):868-876. PubMed ID: 28612910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left atrial appendage occlusion: A review of current devices, clinical evidence, patient selection, and post procedural antithrombotic management.
    Jackson LR; Jackson KP; Thomas KL
    Prog Cardiovasc Dis; 2021; 66():92-100. PubMed ID: 34332665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry.
    Cruz-González I; González-Ferreiro R; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Kanagaratnam P; Nietlispach F; Gloekler S; Aminian A; Danna P; Rezzaghi M; Stock F; Stolcova M; Paiva L; Costa M; Millán X; Ibrahim R; Tichelbäcker T; Schillinger W; Park JW; Sievert H; Meier B; Tzikas A
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):28-34. PubMed ID: 31036510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug.
    Santoro G; Meucci F; Stolcova M; Rezzaghi M; Mori F; Palmieri C; Paradossi U; Pastormerlo LE; Rosso G; Berti S
    EuroIntervention; 2016 Feb; 11(10):1188-94. PubMed ID: 25354761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
    Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke prevention of thoracoscopic left atrial appendage clipping in patients with non-valvular atrial fibrillation at high risk of stroke and bleeding: study protocol for a non-randomised controlled clinical trial.
    Ye C; Han X; Chen Y; Liu F; Ma H; Yang Y; Liu Y; Hu Q; Yao Q; Xie W; Xu D
    BMJ Open; 2022 Oct; 12(10):e063931. PubMed ID: 36307161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation.
    Branzoli S; Marini M; Guarracini F; Pederzolli C; Pomarolli C; D'Onghia G; Centonze M; Fantinel M; Corsini F; Bonmassari R; Graffigna A; La Meir M
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2187-2191. PubMed ID: 32495408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COMPARE LAAO: Rationale and design of the randomized controlled trial "COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagulation therapy".
    Huijboom M; Maarse M; Aarnink E; van Dijk V; Swaans M; van der Heijden J; IJsselmuiden S; Folkeringa R; Blaauw Y; Elvan A; Stevenhagen J; Vlachojannis G; van der Voort P; Westra S; Chaldoupi M; Khan M; de Groot J; van der Kley F; van Mieghem N; van Dijk E; Dijkgraaf M; Tijssen J; Boersma L
    Am Heart J; 2022 Aug; 250():45-56. PubMed ID: 35537503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication.
    Aarnink EW; Maarse M; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zieliński K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; Pérez de Prado A; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Millan X; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; Peper J; van Dijk VF; Rensing BJWM; Swaans MJ; Vireca E; Bergmann MW; Boersma LVA;
    JACC Cardiovasc Interv; 2024 Jun; 17(11):1311-1321. PubMed ID: 38795093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation.
    Mohanty S; Mohanty P; Trivedi C; Assadourian J; Mayedo AQ; MacDonald B; Della Rocca DG; Gianni C; Horton R; Al-Ahmad A; Bassiouny M; Burkhardt JD; Di Biase L; Gurol ME; Natale A
    J Am Heart Assoc; 2021 May; 10(9):e019664. PubMed ID: 33870705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
    Besola L; Gregori D; Fiocco A; Colli A
    Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding.
    Barocelli F; Coli S; Crocamo A; Guidorossi A; Cattabiani MA; Preti F; Bosi D; Spaziani C; Lina D; Menozzi A; Solinas E; Pelà G; Vignali L
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):583-591. PubMed ID: 32443136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.